Prognostic impact of age in advanced non-small cell lung cancer patients undergoing first-line checkpoint inhibitor immunotherapy and chemotherapy treatment

CONCLUSION: Age may not be the primary factor influencing the efficacy of immunotherapy combined with chemotherapy, but particular attention should be given to the elderly population.PMID:38554448 | DOI:10.1016/j.intimp.2024.111901

Source: International Immunopharmacology - March 30, 2024 Category: Allergy & Immunology Authors: Xiaoya Huang Shichao Wu Shubin Chen Moqin Qiu Yun Zhao Jiang Wei Jianbo He Wenhua Zhao Liping Tan Cuiyun Su Shaozhang Zhou Source Type: research